Fibrosis-Inflammation Lab
ホーム
モデル
薬剤
インサイト
研究プランナー
お問い合わせ
ja
⌘
K
Contact
試験プロトコル作成ツール
モデル、動物種、投与スケジュールを選択して、試験デザインを視覚化します。
Study Configuration
1. Study Parameters
Disease Model
Bleomycin-induced Pulmonary Fibrosis
CCl4-induced Liver Fibrosis
Diet-induced MASH/NASH
UUO (Unilateral Ureteral Obstruction)
Species
Mouse
Rat
Animals per Group (N)
2. Treatment Settings
Start Dosing (Day)
Sacrifice (Day)
Route
PO
IV
IP
SC
Frequency
QD
BID
TID
QW
Compound Type
Small Molecule
Antibody
Peptide
Compound Number
1
2
3
Dose Levels
1
2
3
3. Endpoints & Analysis
General Condition
Weight Loss
Biochemistry
Hydroxyproline
TGF-beta levels
Histology
Ashcroft Score
Collagen Area
Other
BALF Cell Count
Study Timeline
Disease Model
Bleomycin-induced Pulmonary Fibrosis
Day 0
Induction
Day 7
Start Dosing
Day 21
Sacrifice
Daily Treatment (PO)
Analysis Plan
No endpoints selected.
Group Configuration
Total Animals: 0
Group
Treatment
N
Route
Frequency
Reference Studies
Bleomycin model of pulmonary fibrosis
Moeller et al. (2008)
Review
Standard Protocol
試験プロトコル作成ツール | Fibrosis-Inflammation Lab | 加速させる、 線維化研究を